acute graft versus host disease |
Disease ID | 1626 |
---|---|
Disease | acute graft versus host disease |
Definition | A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation. |
Synonym | ac graft-versus-host dis acute graft-versus-host disease acute graft-versus-host disease (disorder) acute gvh disease acute gvhd fulminant graft versus host disease graft versus host disease, acute gvhd, acute |
Orphanet | |
ICD10 | |
UMLS | C0856825 |
SNOMED-CT | |
Curated Gene | (Waiting for update.) |
Inferring Gene | Entrez_id | Symbol | Resource(Total Genes:19) 3565 | IL4 | infer 3106 | HLA-B | infer 3107 | HLA-C | infer 3586 | IL10 | infer 3802 | KIR2DL1 | infer 3803 | KIR2DL2 | infer 3804 | KIR2DL3 | infer 3805 | KIR2DL4 | infer 57292 | KIR2DL5A | infer 554300 | KIR2DP1 | infer 3806 | KIR2DS1 | infer 3808 | KIR2DS3 | infer 3809 | KIR2DS4 | infer 3810 | KIR2DS5 | infer 3811 | KIR3DL1 | infer 115653 | KIR3DL3 | infer 548594 | KIR3DP1 | infer 3813 | KIR3DS1 | infer 7124 | TNF | infer |
Text Mined Gene | (Waiting for update.) |
Locus | (Waiting for update.) |
Disease ID | 1626 |
---|---|
Disease | acute graft versus host disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | (Waiting for update.) |
Disease ID | 1626 |
---|---|
Disease | acute graft versus host disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:18) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs10737416 | 22703024 | 7099 | TLR4 | umls:C0856825 | BeFree | The results showed that the genetic markers rs4833079 (P = 0.035) in TLR1, rs4837656 (P = 0.032) and rs17582214 (P = 0.029) in TLR4, rs10737416 (P = 0.048) in TLR5, rs6531656 (P = 0.035) in TLR6, and rs337629 (P = 0.005) in TLR10 were associated with the occurrence of acute GvHD. | 0.000814326 | 2012 | LOC105373109 | 1 | 224887055 | C | A |
rs11209026 | 18209723 | 149233 | IL23R | umls:C0856825 | BeFree | Among recipients of hematopoietic cells from HLA-identical donors, the IL-23R (Arg381Gln) gene variant on the donor side has a protective effect on the occurrence of acute GVHD in recipients after transplantation. | 0.000814326 | 2008 | IL23R | 1 | 67240275 | G | A |
rs17582214 | 22703024 | 7099 | TLR4 | umls:C0856825 | BeFree | The results showed that the genetic markers rs4833079 (P = 0.035) in TLR1, rs4837656 (P = 0.032) and rs17582214 (P = 0.029) in TLR4, rs10737416 (P = 0.048) in TLR5, rs6531656 (P = 0.035) in TLR6, and rs337629 (P = 0.005) in TLR10 were associated with the occurrence of acute GvHD. | 0.000814326 | 2012 | NA | 9 | 119676531 | A | T |
rs1800795 | 22282500 | 3569 | IL6 | umls:C0856825 | BeFree | Similar to previous publications, the IL6 donor genotype for rs1800795 was associated with a 20%-50% increased risk for grade IIb-IV aGVHD after unrelated HCT in the allelic (adjusted P = .011) and recessive (adjusted P = .0013) models. | 0.002442977 | 2012 | IL6;LOC541472 | 7 | 22727026 | C | G |
rs2910164 | 25205119 | 406938 | MIR146A | umls:C0856825 | BeFree | In humans, the minor genotype of the single nucleotide polymorphism rs2910164 in HCT donors, which reduces expression of miR-146a, was associated with severe acute GVHD (grade III/IV). | 0.000271442 | 2014 | LOC285628;MIR146A | 5 | 160485411 | C | G |
rs337629 | 22703024 | 7099 | TLR4 | umls:C0856825 | BeFree | The results showed that the genetic markers rs4833079 (P = 0.035) in TLR1, rs4837656 (P = 0.032) and rs17582214 (P = 0.029) in TLR4, rs10737416 (P = 0.048) in TLR5, rs6531656 (P = 0.035) in TLR6, and rs337629 (P = 0.005) in TLR10 were associated with the occurrence of acute GvHD. | 0.000814326 | 2012 | KLF3-AS1 | 4 | 38633737 | A | G |
rs352139 | 24121213 | 54106 | TLR9 | umls:C0856825 | BeFree | We found that two tagSNPs in the TLR9 gene in the donor side, +1174 A/G (rs352139) and +1635 C/T (rs352140), influenced the risk of acute GVHD (aGVHD) and CMV reactivation. | 0.000542884 | 2013 | TLR9 | 3 | 52224356 | T | C |
rs352140 | 24121213 | 54106 | TLR9 | umls:C0856825 | BeFree | We found that two tagSNPs in the TLR9 gene in the donor side, +1174 A/G (rs352139) and +1635 C/T (rs352140), influenced the risk of acute GVHD (aGVHD) and CMV reactivation. | 0.000542884 | 2013 | TLR9 | 3 | 52222681 | C | A,T |
rs4364254 | 20075159 | 10855 | HPSE | umls:C0856825 | BeFree | The present study indicates a highly significant correlation of HPSE gene SNPs rs4693608 and rs4364254 and their combination with the risk of developing acute GVHD. | 0.000271442 | 2010 | HPSE;LOC105377313 | 4 | 83302560 | C | T |
rs4553808 | 24057239 | 1493 | CTLA4 | umls:C0856825 | BeFree | Finally, finding of significant associations between CD28 +17 C/T and CTLA4 -1661 A/G genotypes with CMV active infection in allogeneic HSCT patients experienced aGVHD emphasize on the importance of the genetic pattern of costimulatory genes in outcomes of active CMV infection in HSCT patients needs completed studies. | 0.001900093 | 2013 | CTLA4 | 2 | 203866282 | A | G |
rs4693608 | 20075159 | 10855 | HPSE | umls:C0856825 | BeFree | The present study indicates a highly significant correlation of HPSE gene SNPs rs4693608 and rs4364254 and their combination with the risk of developing acute GVHD. | 0.000271442 | 2010 | HPSE | 4 | 83320204 | G | A |
rs4833079 | 22703024 | 7099 | TLR4 | umls:C0856825 | BeFree | The results showed that the genetic markers rs4833079 (P = 0.035) in TLR1, rs4837656 (P = 0.032) and rs17582214 (P = 0.029) in TLR4, rs10737416 (P = 0.048) in TLR5, rs6531656 (P = 0.035) in TLR6, and rs337629 (P = 0.005) in TLR10 were associated with the occurrence of acute GvHD. | 0.000814326 | 2012 | KLF3-AS1 | 4 | 38653060 | T | C |
rs4837656 | 22703024 | 7099 | TLR4 | umls:C0856825 | BeFree | The results showed that the genetic markers rs4833079 (P = 0.035) in TLR1, rs4837656 (P = 0.032) and rs17582214 (P = 0.029) in TLR4, rs10737416 (P = 0.048) in TLR5, rs6531656 (P = 0.035) in TLR6, and rs337629 (P = 0.005) in TLR10 were associated with the occurrence of acute GvHD. | 0.000814326 | 2012 | NA | 9 | 119671775 | T | C |
rs4986791 | 16436969 | 64127 | NOD2 | umls:C0856825 | BeFree | Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. | 0.001900093 | 2006 | TLR4 | 9 | 117713324 | C | T |
rs4986791 | 16436969 | 7099 | TLR4 | umls:C0856825 | BeFree | Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. | 0.000814326 | 2006 | TLR4 | 9 | 117713324 | C | T |
rs6531656 | 22703024 | 7099 | TLR4 | umls:C0856825 | BeFree | The results showed that the genetic markers rs4833079 (P = 0.035) in TLR1, rs4837656 (P = 0.032) and rs17582214 (P = 0.029) in TLR4, rs10737416 (P = 0.048) in TLR5, rs6531656 (P = 0.035) in TLR6, and rs337629 (P = 0.005) in TLR10 were associated with the occurrence of acute GvHD. | 0.000814326 | 2012 | KLF3 | 4 | 38682580 | C | T |
rs6844176 | 20574454 | 5981 | RFC1 | umls:C0856825 | BeFree | In multivariate analysis, one SNP (rs6844176) in RFC1 (replication factor C (activator 1)) gene was independently associated with a higher risk of grade II-IV acute GVHD (relative risk (RR): 1.39, 95% confidence interval (CI): 1.14-1.70, P=0.001), and showed a trend toward higher risk of grade III-IV acute GVHD (RR: 1.33, 95% CI: 0.95-1.85, P=0.09). | 0.000271442 | 2010 | RFC1 | 4 | 39364970 | T | C |
rs9277534 | 26267621 | 3115 | HLA-DPB1 | umls:C0856825 | BeFree | Among recipients of transplants from donors with rs9277534A-linked HLA-DPB1, the risk of acute GVHD was higher for recipients with rs9277534G-linked HLA-DPB1 mismatches than for recipients with rs9277534A-linked HLA-DPB1 mismatches (hazard ratio, 1.54; 95% confidence interval [CI], 1.25 to 1.89; P<0.001), as was the risk of death due to causes other than disease recurrence (hazard ratio, 1.25; 95% CI, 1.00 to 1.57; P=0.05). | 0.002985861 | 2015 | HLA-DPB1 | 6 | 33087030 | A | G |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |